Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A for dry eye and visual quality after refractive surgery
ChiCTR2500104011Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cyclosporine in dry eye syndrome (DED) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Ocular Surface Disease Index score, Corneal topography by Pentacam and 2 more. Started Jun 2025; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2500104011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104011.